Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Non-Current Assets (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Non-Current Assets for 5 consecutive years, with $915000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 87.28% to $915000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.5 million through Dec 2025, down 66.84% year-over-year, with the annual reading at $915000.0 for FY2025, 87.28% down from the prior year.
  • Non-Current Assets hit $915000.0 in Q4 2025 for Kezar Life Sciences, down from $3.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $19.9 million in Q2 2023 to a low of $915000.0 in Q4 2025.
  • Historically, Non-Current Assets has averaged $9.2 million across 5 years, with a median of $6.5 million in 2021.
  • Biggest five-year swings in Non-Current Assets: soared 222.78% in 2023 and later tumbled 87.28% in 2025.
  • Year by year, Non-Current Assets stood at $6.3 million in 2021, then skyrocketed by 120.51% to $13.8 million in 2022, then grew by 3.17% to $14.3 million in 2023, then plummeted by 49.64% to $7.2 million in 2024, then tumbled by 87.28% to $915000.0 in 2025.
  • Business Quant data shows Non-Current Assets for KZR at $915000.0 in Q4 2025, $3.2 million in Q3 2025, and $4.4 million in Q2 2025.